Robert Mróz
Impact in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Respiratory Support and Mechanisms
- Physiology top 10%
- Asthma and respiratory diseases
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 25
- Lung Cancer Treatments and Mutations 6
- Respiratory Support and Mechanisms 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Inhalation and Respiratory Drug Delivery 4
- Co-authors
- E Chyczewska (32 shared papers)Adam Hołownia (20 shared papers)William MacNee (6 shared papers)Jan J. Braszko (18 shared papers)Ellen Drost (3 shared papers)Roel P. F. Schins (2 shared papers)Anna Stasiak‐Barmuta (7 shared papers)Kenneth Donaldson (2 shared papers)
- Journals
- Advances in experimental medicine and biology (10 papers)European Respiratory Journal (3 papers)Cancers (3 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (2 papers)International Journal of COPD (2 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Robert Mróz
72 papers receiving 810 citations
Peers
Comparison fields: 5 of 109
- Pulmonary and Respiratory Medicine 351
- Physiology 179
- Cancer Research 92
- Health, Toxicology and Mutagenesis 68
- Developmental Neuroscience 18
Countries citing papers authored by Robert Mróz
This map shows the geographic impact of Robert Mróz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mróz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mróz more than expected).
Fields of papers citing papers by Robert Mróz
This network shows the impact of papers produced by Robert Mróz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mróz. The network helps show where Robert Mróz may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Mróz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 119 | |
| 2 | 2013 | 87 | |
| 3 | Nanoparticle carbon black driven DNA damage induces growth arrest and AP-1 and NFkappaB DNA binding in lung epithelial A549 cell line. | 2007 | 55 |
| 4 | Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study. | 2015 | 45 |
| 5 | Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. | 2007 | 31 |
| 6 | Severe respiratory distress caused by central airway obstruction treated with self-expandable metallic stents. | 2008 | 29 |
| 7 | 2021 | 28 | |
| 8 | Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. | 2008 | 24 |
| 9 | 2019 | 22 | |
| 10 | Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. | 2007 | 22 |
| 11 | 2019 | 18 | |
| 12 | 2009 | 17 | |
| 13 | 2024 | 17 | |
| 14 | 2014 | 17 | |
| 15 | 2009 | 17 | |
| 16 | Propofol protects rat astroglial cells against tert-butyl hydroperoxide-induced cytotoxicity; the effect on histone and cAMP-response-element-binding protein (CREB) signalling. | 2009 | 16 |
| 17 | 2023 | 12 | |
| 18 | 2021 | 12 | |
| 19 | Upregulation of Th1 cytokine profile in bronchoalveolar lavage fluid of patients with hypersensitivity pneumonitis. | 2008 | 12 |
| 20 | [Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD]. | 2002 | 11 |
About Robert Mróz
Robert Mróz is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Physiology, Oncology and Cancer Research, having authored 81 papers that have together received 840 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers), Asthma and respiratory diseases (9 papers), Lung Cancer Treatments and Mutations (6 papers), Respiratory Support and Mechanisms (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (351 citations), Physiology (179 citations), Cancer Research (92 citations), Health, Toxicology and Mutagenesis (68 citations) and Developmental Neuroscience (18 citations). Robert Mróz has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include E Chyczewska, Adam Hołownia, William MacNee, Jan J. Braszko, Ellen Drost, Roel P. F. Schins, Anna Stasiak‐Barmuta, Kenneth Donaldson, Esther García Gil and Rosa Segarra. Their work appears in journals such as Advances in experimental medicine and biology, European Respiratory Journal, Cancers, Naunyn-Schmiedeberg s Archives of Pharmacology and International Journal of COPD.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.